Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Case Reports in Oncology|April 30, 2013
Long-Term Treatment with Erlotinib for EGFR Wild-Type Non-Small Cell Lung Cancer: A Case ReportGenovefa Polychronidou, Pavlos Papakotoulas
Future Oncology (London, England)|January 31, 2017
Novel therapeutic approaches in chondrosarcomaGenovefa Polychronidou, Vasilios Karavasilis, Seth M Pollack, et al.
Journal of Global Oncology|September 28, 2018
Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and OpportunitiesElena Fountzilas, Sofia Levva, Giannis Mountzios, et al.
Journal of Clinical Medicine|July 15, 2026
Characterizing Gynecological Cancers with the Uncommon dMMR/MSS Phenotype in Lynch Syndrome PatientsGeorgios Koktsidis, Davide Mauri, Stylianos Elemes, et al.
Plos One|December 7, 2018
Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancerGenovefa Polychronidou, Vassiliki Kotoula, Kyriaki Manousou, et al.
International Journal of Cancer|December 17, 2024
Incidence, characteristics and outcome of therapy-related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase inhibitors: A cancer center experienceEvgenia Verrou, Prodromos Koutoukoglou, Evangelia Kontana, et al.
Journal of Translational Medicine|January 14, 2012
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapyGeorge Fountzilas, Christos Valavanis, Vassiliki Kotoula, et al.
ESMO Open|June 25, 2019
Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancerElena Fountzilas, Vassiliki Kotoula, George Pentheroudakis, et al.
American Journal of Hematology|April 24, 2014
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patientsEirini Katodritou, Evangelos Terpos, Argiris S Symeonidis, et al.
Annals of Hematology|October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experienceEirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
Pageof 1